NCT07523815 Artificial Intelligence Assisted Workflow Versus Conventional Workflow in Guided Implant Placement
| NCT ID | NCT07523815 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Sandra Moussa Botros El Tarzi |
| Condition | Partially Edentulous Mandible |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 20 participants in total. It began in 2026-05-01 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The AI assisted CAD/CAM workflow will be adopted for the treatment planning and guide design generation with the aim of comparing precision of implant placement with conventional digital workflow.
Eligibility Criteria
Inclusion Criteria: * Kennedy class III partially edentulous patient with or without modifications. * Patients who need single implant posterior site delayed implant placement. * Patients above 18 and below 60 years of age. * Natural healthy neighboring teeth without need of new restorations. Exclusion Criteria: * Patients with D4 bone density. * Patients with known systemic or local diseases or treatments which can affect normal tissue healing. * Patients who are heavy smokers. * Presence of signs of active infection or pus formation. * Patients with a need for implants in the anterior region. * Additional oral surgery in the region of interest. * Need For Bone grafting. * Pregnant and/or lactating women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07523815 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Partially Edentulous Mandible. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07523815 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07523815 currently recruiting?
Yes, NCT07523815 is actively recruiting participants. Contact the research team at sandra.eltarzi@dentistry.cu.edu.eg for enrollment information.
Where is the NCT07523815 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07523815 clinical trial?
NCT07523815 is sponsored by Sandra Moussa Botros El Tarzi. The trial plans to enroll 20 participants.